UNIVERSITY OF MIAMI

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1925-01-01

Employees: 10K

Market Cap: -

Website: https://continue.miami.edu/packagedetail.aspx

Clinical Trials

Tear Dynamics After Restasis Treatment in Dry Eye Patients

Completed

Conditions: Dry Eye

First Posted Date: 2008-06-30

Last Posted Date: 2017-04-25

Lead Sponsor: University of Miami

Target Recruit Count: 60

Registration Number: NCT00706940

Locations: 🇺🇸
Bascom Palmer Eye Institute, Miami, Florida, United States

Phase II/III Randomized, Placebo-controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis

Phase 2

Completed

Conditions: Amyotrophic Lateral Sclerosis

Interventions: Drug: Placebo
Drug: Arimoclomol

First Posted Date: 2008-06-27

Last Posted Date: 2019-01-11

Lead Sponsor: University of Miami

Target Recruit Count: 38

Registration Number: NCT00706147

Locations: 🇺🇸
University of Miami Miller School of Medicine, Miami, Florida, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Abraxane Therapy in Patients With Pancreatic Cancer Who Failed First-Line Gemcitabine Therapy

Phase 2

Completed

Conditions: Pancreatic Cancer

Interventions: Drug: Abraxane

First Posted Date: 2008-06-05

Last Posted Date: 2017-05-11

Lead Sponsor: University of Miami

Target Recruit Count: 20

Registration Number: NCT00691054

Locations: 🇸🇬
Johns Hopkins Singapore International Medical Centre, Singapore, Singapore
🇺🇸
University of Miami Sylvester Comprehensive Cancer Center - Miami, Miami, Florida, United States

Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Deceased Donor Renal Transplantation

Phase 4

Completed

Conditions: Renal Transplantation

Interventions: Drug: Campath-1H
Drug: Daclizumab
Drug: Thymoglobulin

First Posted Date: 2008-05-28

Last Posted Date: 2023-10-18

Lead Sponsor: University of Miami

Target Recruit Count: 90

Registration Number: NCT00685061

Locations: 🇺🇸
University of Miami Division of Transplantation, Miami, Florida, United States

Tacrolimus/Sirolimus Versus Tacrolimus/Mycophenolate Mofetil (MMF) Versus Neoral/Sirolimus in Adult, Primary Kidney Transplantation

Phase 4

Completed

Conditions: Adult Primary Kidney Transplantation

Interventions: Drug: Tacrolimus/Sirolimus
Drug: Neoral/Sirolimus
Drug: Tacrolimus/MMF

First Posted Date: 2008-05-21

Last Posted Date: 2023-09-22

Lead Sponsor: University of Miami

Target Recruit Count: 150

Registration Number: NCT00681213

Locations: 🇺🇸
University of Miami Division of Transplantation, Miami, Florida, United States

Safety of Vitamin D Supplementation in Older Persons

Phase 3

Completed

Conditions: Vitamin D Deficiency

Interventions: Dietary Supplement: cholecalciferol (vitamin D)

First Posted Date: 2008-05-21

Last Posted Date: 2017-01-26

Lead Sponsor: University of Miami

Target Recruit Count: 105

Registration Number: NCT00681590

Locations: 🇺🇸
University of Miami, Miami, Florida, United States

Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Living Donor Renal Transplantation

Phase 4

Completed

Conditions: Living-Donor Kidney Transplant

Interventions: Drug: Campath-1H
Drug: Thymoglobulin
Drug: Daclizumab

First Posted Date: 2008-05-21

Last Posted Date: 2023-09-14

Lead Sponsor: University of Miami

Target Recruit Count: 38

Registration Number: NCT00681343

Locations: 🇺🇸
University of Miami Division of Transplantation, Miami, Florida, United States

Three Interacting Single Nucleotide Polymorphisms (SNPs) and the Risk of Preterm Birth in Black Families

Terminated

Conditions: Premature Birth

Interventions: Genetic: Blood spot specimens will be drawn

First Posted Date: 2008-05-12

Last Posted Date: 2015-12-17

Lead Sponsor: University of Miami

Target Recruit Count: 258

Registration Number: NCT00675753

Locations: 🇺🇸
Broward Medical Center, Ft. Lauderdale, Florida, United States
🇺🇸
Broward General Medical Center, Ft Lauderdale, Florida, United States

Primary Tube Versus Trabeculectomy Study

Phase 4

Completed

Conditions: Glaucoma

Interventions: Procedure: Tube shunt surgery
Procedure: Trabeculectomy
Drug: Mitomycin C

First Posted Date: 2008-04-24

Last Posted Date: 2022-10-19

Lead Sponsor: University of Miami

Target Recruit Count: 242

Registration Number: NCT00666237

Locations: 🇺🇸
St. Louis University, Saint Louis, Missouri, United States
🇺🇸
New York Eye and Ear Infirmary, New York, New York, United States
🇺🇸
University of Virginia, Charlottesville, Virginia, United States

and more 13 locations

Effects of Leptin Replacement in Children

Phase 2

Completed

Conditions: Obesity
Diabetes
Metabolic Syndrome

Interventions: Drug: Recombinant methionyl human leptin

First Posted Date: 2008-04-16

Last Posted Date: 2020-02-13

Lead Sponsor: University of Miami

Target Recruit Count: 1

Registration Number: NCT00659828

Locations: 🇺🇸
University of Miami, Center on Pharmacogenomics, Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy